Bernadette T Gillick1, Linda E Krach2, Tim Feyma3, Tonya L Rich3, Kelli Moberg3, Jeremiah Menk4, Jessica Cassidy5, Teresa Kimberley5, James R Carey5. 1. Department of Physical Medicine and Rehabilitation, University of Minnesota Medical School, Minneapolis, MN. Electronic address: gillick@umn.edu. 2. Department of Physical Medicine and Rehabilitation, University of Minnesota Medical School, Minneapolis, MN; Gillette Children's Specialty Healthcare, St Paul, MN. 3. Gillette Children's Specialty Healthcare, St Paul, MN. 4. University of Minnesota Clinical and Translational Science Institute Biostatistical Design and Analysis Center, Minneapolis, MN. 5. Department of Physical Medicine and Rehabilitation, University of Minnesota Medical School, Minneapolis, MN.
Abstract
OBJECTIVE: To investigate the safety of combining a 6-Hz primed low-frequency repetitive transcranial magnetic stimulation (rTMS) intervention in the contralesional hemisphere with a modified constraint-induced movement therapy (mCIMT) program in children with congenital hemiparesis. DESIGN: Phase 1 randomized, double-blinded, placebo-controlled pretest/posttest trial. SETTING:University academic facility and pediatric specialty hospital. PARTICIPANTS: Subjects (N = 19; age range, 8-17 y) with congenital hemiparesis caused by ischemic stroke or periventricular leukomalacia. No subject withdrew because of adverse events. All subjects included completed the study. INTERVENTIONS: Subjects were randomized to 1 of 2 groups: either real rTMS plus mCIMT (n = 10) or sham rTMS plusmCIMT (n = 9). MAIN OUTCOME MEASURES: Adverse events, physician assessment, ipsilateral hand function, stereognosis, cognitive function, subject report of symptoms assessment, and subject questionnaire. RESULTS: No major adverse events occurred. Minor adverse events were found in both groups. The most common events were headaches (real: 50%, sham: 89%; P = .14) and cast irritation (real: 30%, sham: 44%; P = .65). No differences between groups in secondary cognitive and unaffected hand motor measures were found. CONCLUSIONS:Primed rTMS can be used safely with mCIMTin congenital hemiparesis. We provide new information on the use of rTMS in combination with mCIMT in children. These findings could be useful in research and future clinical applications in advancing function in congenital hemiparesis.
RCT Entities:
OBJECTIVE: To investigate the safety of combining a 6-Hz primed low-frequency repetitive transcranial magnetic stimulation (rTMS) intervention in the contralesional hemisphere with a modified constraint-induced movement therapy (mCIMT) program in children with congenital hemiparesis. DESIGN: Phase 1 randomized, double-blinded, placebo-controlled pretest/posttest trial. SETTING: University academic facility and pediatric specialty hospital. PARTICIPANTS: Subjects (N = 19; age range, 8-17 y) with congenital hemiparesis caused by ischemic stroke or periventricular leukomalacia. No subject withdrew because of adverse events. All subjects included completed the study. INTERVENTIONS: Subjects were randomized to 1 of 2 groups: either real rTMS plus mCIMT (n = 10) or sham rTMS plus mCIMT (n = 9). MAIN OUTCOME MEASURES: Adverse events, physician assessment, ipsilateral hand function, stereognosis, cognitive function, subject report of symptoms assessment, and subject questionnaire. RESULTS: No major adverse events occurred. Minor adverse events were found in both groups. The most common events were headaches (real: 50%, sham: 89%; P = .14) and cast irritation (real: 30%, sham: 44%; P = .65). No differences between groups in secondary cognitive and unaffected hand motor measures were found. CONCLUSIONS: Primed rTMS can be used safely with mCIMT in congenital hemiparesis. We provide new information on the use of rTMS in combination with mCIMT in children. These findings could be useful in research and future clinical applications in advancing function in congenital hemiparesis.
Authors: Adriana B Conforto; Sarah M Anjos; Gustavo Saposnik; Eduardo A Mello; Erina M Nagaya; Waldyr Santos; Karina N Ferreiro; Eduardo S Melo; Felipe I Reis; Milberto Scaff; Leonardo G Cohen Journal: J Neurol Date: 2011-12-16 Impact factor: 4.849
Authors: James R Carey; Chad D Evans; David C Anderson; Ela Bhatt; Ashima Nagpal; Teresa J Kimberley; Alvaro Pascual-Leone Journal: Neurorehabil Neural Repair Date: 2007-09-17 Impact factor: 3.919
Authors: Tonya Rich; Jessica Cassidy; Jeremiah Menk; Ann Van Heest; Linda Krach; James Carey; Bernadette T Gillick Journal: Dev Neurorehabil Date: 2016-03-17 Impact factor: 2.308
Authors: Maíra C Lixandrão; James W Stinear; Tonya Rich; Chao-Ying Chen; Tim Feyma; Gregg D Meekins; Bernadette T Gillick Journal: Braz J Phys Ther Date: 2018-11-22 Impact factor: 3.377
Authors: Jessica M Cassidy; James R Carey; Chiahao Lu; Linda E Krach; Tim Feyma; William K Durfee; Bernadette T Gillick Journal: Res Dev Disabil Date: 2015-09-29